Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials.

Aún no traducido Aún no traducido
Autores
Categoría Revisión sistemática
RevistaBiomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
Año 2007
Cargando información sobre las referencias
To determine whether anti-tumor necrosis factors induce clinical response and remission in patients with Crohn's disease, PUBMED, OVID, and SCOPUS databases were searched for studies investigated the efficacy of anti-tumor necrosis factors on CD. Data were collected from 1966 to 2005 (up to 31 December). Types of outcome investigated were response (decrease in CDAI score >/=70 points) and remission (CDAI score






Epistemonikos ID.: 3c7f41d3765a637470fcf2e3d4c59cd691105d1d


First added on: Jul 07, 2016